MR Shey, ZK Ballas. (2008) " Assessment of natural killer (NK) and NKT cells in murine spleens and livers. " Methods Mol Biol 447. 259-76 PMID: 18369924 DOI: 10.1007/978-1-59745-242-7_18 | Abstract and Keywords

GJ Renukaradhya, MA Khan, M Vieira, W Du, J Gervay-Hague, RR Brutkiewicz. (2008) " Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma. " Blood 111. 5637-45 PMID: 18417738 DOI: 10.1182/blood-2007-05-092866 | Abstract and Keywords

JQ Jiang, XS He, N Feng, HB Greenberg. (2008) " Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection. " J Virol 82. 6812-9 PMID: 18480435 DOI: 10.1128/JVI.00450-08 | Abstract and Keywords

JD Wesley, MS Tessmer, D Chaukos, L Brossay. (2008) " NK cell-like behavior of Valpha14i NK T cells during MCMV infection. " PLoS Pathog 4. e1000106 PMID: 18636102 DOI: 10.1371/journal.ppat.1000106 | Abstract and Keywords

E Billerbeck, N Nakamoto, B Seigel, HE Blum, KM Chang, R Thimme. (2009) " Determinants of in vitro expansion of different human virus-specific FoxP3+ regulatory CD8+ T cells in chronic hepatitis C virus infection. " J Gen Virol 90. 1692-701 PMID: 19321758 DOI: 10.1099/vir.0.009837-0 | Abstract and Keywords

M Honda, R Wang, WP Kong, M Kanekiyo, W Akahata, L Xu, K Matsuo, K Natarajan, H Robinson, TE Asher, DA Price, DC Douek, DH Margulies, GJ Nabel. (2009) " Different vaccine vectors delivering the same antigen elicit CD8+ T cell responses with distinct clonotype and epitope specificity. " J Immunol 183. 2425-34 PMID: 19620307 DOI: 10.4049/jimmunol.0900581 | Abstract and Keywords

TG Jones, J Hallgren, A Humbles, T Burwell, FD Finkelman, P Alcaide, KF Austen, MF Gurish. (2009) " Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. " J Immunol 183. 5251-60 PMID: 19783672 DOI: 10.4049/jimmunol.0901471 | Abstract and Keywords

S Lee, H Yagita, TJ Sayers, E Celis. (2010) " Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors. " Cancer Immunol Immunother 59. 1073-81 PMID: 20213120 DOI: 10.1007/s00262-010-0834-0 | Abstract and Keywords

H Lu, WM Wagner, E Gad, Y Yang, H Duan, LM Amon, N Van Denend, ER Larson, A Chang, H Tufvesson, ML Disis. (2010) " Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade. " J Immunol 184. 5360-7 PMID: 20308630 DOI: 10.4049/jimmunol.0902997 | Abstract and Keywords

M Nowak, MS Arredouani, A Tun-Kyi, I Schmidt-Wolf, MG Sanda, SP Balk, MA Exley. (2010) " Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with alpha-galactosylceramide. " PLoS One 5. e11311 PMID: 20593019 DOI: 10.1371/journal.pone.0011311 | Abstract and Keywords